ArticleFrontiers in immunology2021

Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization.

Mengzhou Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.